High prevalence of CNS-directed autoantibodies in patients with schizophrenia
Katlyn Nemani, Jillian R. Jaycox, Uğur Akcan, Benjamin M. Schuman, Sung M. Yeon, Nina Harano, Kai Qin, Alison Figueroa Almeda, Sean M. Carroll, Brent S. McKenzie, Leon Furchtgott, Adrienne Carol Lahti, Richard W. Tsien, Dritan Agalliu, DONALD C. GOFF, Aaron M. Ring
This study identifies a high prevalence of CNS-directed autoantibodies in schizophrenia patients, linking them to disease severity, treatment resistance, and potential therapeutic targets.
bioRxiv · May 7, 2026 · PreprintImmunology